Longevity News

Design and characterization of an injectable biohybrid hydrogel based on chitosan/silk fibroin/hyaluronic acid and containing bioactive glass for bone tissue engineering

Source: Nature - Biotechnology • Published: 27 Aug 2026, 00:00

Design and characterization of an injectable biohybrid hydrogel based on chitosan/silk fibroin/hyaluronic acid and containing bioactive glass for bone tissue engineering

Covers development and lab characterization of an injectable biohybrid hydrogel combining natural polymers and bioactive glass for bone repair applications.

Key Takeaways
  • It is citable and carries a permanent DOI
  • This version is subject to further edits and will be replaced automatically by the final Version of Record
  • Calcium ion release from the hydrogel was measured and modeled
Read Original Source

Continue exploring

Related longevity signals

Frontiers - HealthMachine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes in Breast Cancer Histopathology: A Systematic Review and Evidence-Gap Analysis of Translational ReadinessAssessments of tumor-infiltrating lymphocytes in breast cancer using machine learning are reviewed and mapped for translational readiness and methodological gaps.Nature - BiotechnologyA CRISPR-based ‘dam-break drainage’ sensing architecture for rapid, affordable and ultrasensitive pathogen detectionA chip-based CRISPR-Cas13a fluidic sensor translates target RNA into a visible dam-break drainage signal for rapid, instrument-free detection.Nature - BiotechnologyVirus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cellsA methods-focused article describing a virus-like particle toolkit for delivering diverse CRISPR edits and enabling pooled functional genomics in primary human myeloid cells.Nature - BiotechnologyPhotochemical internalization enhances in vivo immunity to peptide‑ and protein‑based vaccines with synthetic dsRNA adjuvantsPhotochemical internalization as a strategy to boost immune responses to peptide- and protein-based vaccines paired with synthetic dsRNA adjuvants; a research article preview inviting readers to learn how this method was evaluated in preclinical models.